Tossing the coin of ESBL: Prevalence of ESBL-producing Klebsiella pneumoniae isolated from patients with sepsis.

preprint OA: closed
Full text JSON View at publisher
Full text 2,269 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Abstract

Background. Klebsiella pneumoniae is part of the ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp) group of MDR pathogens. It is the second leading cause of nosocomial bloodstream infections, and it has a propensity to be drug resistant. Therefore, it was aimed to determine the antibiotic resistance patterns of K. pneumoniae isolated from blood cultures of patients with features of sepsis at Mulago National Referral Hospital, Uganda.

Methods

The cross-sectional study on patients with features of sepsis utilised K. pneumoniae (N= 30) isolated from positive blood culture specimens. The antibiotic resistance profile was determined by the Clinical and Laboratory Standards Institute’s Kirby Bauer disk diffusion method, which was used to classify the isolates as susceptible, intermediate, and resistant. K. pneumoniae isolates that were resistant to third generation cephalosporins were subjected to extended spectrum b-lactamase (ESBL) screening and confirmation using the double-disk synergy test using cefotaxime, ceftazidime, ceftriaxone, cefotaxime-clavulanic acid, and ceftazidime-clavulanic acid. The results were analysed for frequencies. Results. K. pneumoniae isolates showed minimum resistance to imipenem 13% (4/30) followed by amikacin 17% (5/30). There was intermediate resistance to gentamycin 60% (18/30). However, K. pneumoniae showed the highest resistance to piperacillin; 100% (30/30) followed by sulphamethoxazole-trimethoprim and cefepime both showing a percentage of 97% (29/30). Up to 16/30 (53.3%) of K. pneumoniae were positive for ESBL production while 14/30 (46.7%) were negative. Conclusion. There was a high prevalence of antibiotic resistant ESBL-producing K pneumoniae isolates from bloodstream infection of patients with features of sepsis in Uganda’s Mulago National Referral Hospital. - Received: - Version Posted: Funding - European and Developing Countries Clinical Trials Partnership (Award TMA2018CDF-2371) - Principal Award Recipient: Beatrice Achan - MAKRIF (Award Not given) - Principal Award Recipient: Beatrice Achan - NURTURE/NIH (Award D43TW010132) - Principal Award Recipient: Beatrice Achan

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00